.txt.34642


24.08.2005 1-18-185
" "

:












24 2005 . 1-18-185





, . 70%.
12.09.2005 (), . - .
, , .



..








24 2005 . 1-18-185

   ----------------------------------------------------T------------



(
)
+---------------------------------------------------+------------+
-, . 10, Novartis pharma 8,5
+---------------------------------------------------+------------+
, . 24, 7,5
+---------------------------------------------------+------------+
, 170 1, Actavis 47,5
+---------------------------------------------------+------------+
, . 30 20, Ratiopharm 43
International
+---------------------------------------------------+------------+
-, 6,5
500 1, -
+---------------------------------------------------+------------+
, . 500 10, 2
+---------------------------------------------------+------------+
-, . / 100 10, 145
+---------------------------------------------------+------------+
-, . / 50 10, 87
+---------------------------------------------------+------------+
, . 50, - 13,5
+---------------------------------------------------+------------+
, . 350 50, 11,59
+---------------------------------------------------+------------+
, . / 50 30, Nycomed 42,9
+---------------------------------------------------+------------+
, 400 20 1, Servier 210
+---------------------------------------------------+------------+
8 -, 8 25, Berlin- 19
Chemie/Menarini group
+---------------------------------------------------+------------+
, . / 20 50, 9,7

+---------------------------------------------------+------------+
, . 60 10, 3,4
-
+---------------------------------------------------+------------+
, 50 1, 70
Krewel Meuselbach GmbH
+---------------------------------------------------+------------+
, . 25 1, 12
+---------------------------------------------------+------------+
, 25 , 15
+---------------------------------------------------+------------+
, . 25 20, Sanofi-Synthelabo 55
+---------------------------------------------------+------------+
, . 10, GSK Pharmaceuticals 5,7
+---------------------------------------------------+------------+
, 0,25% - 105,6
10 1,
+---------------------------------------------------+------------+
, 100 10, 8,58

+---------------------------------------------------+------------+
, 0,1% 10 1, Novartis 55
Consumer
+---------------------------------------------------+------------+
, . 2 20, Janssen-Cilag 150
+---------------------------------------------------+------------+
, 5% - 10 1, 5,5

+---------------------------------------------------+------------+
, . 5 50, Gedeon Richter 125
+---------------------------------------------------+------------+
, . 25 40, 125
+---------------------------------------------------+------------+
, 35 80, Sopharma 78
+---------------------------------------------------+------------+
, . 10, 50
+---------------------------------------------------+------------+
, . 10 10, Ranbaxy laboratories Ltd. 23
+---------------------------------------------------+------------+
, . 10, Ranbaxy 42
laboratories Ltd.
+---------------------------------------------------+------------+
, 25 1, 6,4

+---------------------------------------------------+------------+
, . 16, LEK 120
+---------------------------------------------------+------------+
, 15 1, Aventis 6
+---------------------------------------------------+------------+
, . / 20, Berlin-Chemie/Menarini 40
group
+---------------------------------------------------+------------+
, 20 , Unique pharmaceutical 31,9
laboratories
+---------------------------------------------------+------------+
, (. ) 0,05% - 10 1, 55
Nycomed
+---------------------------------------------------+------------+
, 25,7
0,9% - 200 1,
+---------------------------------------------------+------------+
, 0,1% 10 , 6
+---------------------------------------------------+------------+
, . 0,5 40, - 13
+---------------------------------------------------+------------+
, . 10 25, 6
+---------------------------------------------------+------------+
-, . 40 20, Sanofi-Synthelabo 48
+---------------------------------------------------+------------+
-, . 40 100, Sanofi-Synthelabo 135
+---------------------------------------------------+------------+
, 10, 25
+---------------------------------------------------+------------+
, . 20 30, Dr. Reddy's 156
+---------------------------------------------------+------------+
, 50, Gedeon Richter 52
+---------------------------------------------------+------------+
, . 50 30, 45
+---------------------------------------------------+------------+
, 10 1, Zentiva 29
+---------------------------------------------------+------------+
, . / 150 20, 23
+---------------------------------------------------+------------+
, . 10 14, Merk Sharp & Dome 80,8
+---------------------------------------------------+------------+
, . 200 50, -/ 17,7
+---------------------------------------------------+------------+
, 0,1% 10 , IVAX 30
+---------------------------------------------------+------------+
, . 20, Cipla Ltd. 6,4
+---------------------------------------------------+------------+
, 0,025% - 15 1, 13
+---------------------------------------------------+------------+
, () 3 10, Beaufour-Ipsen 118
international
+---------------------------------------------------+------------+
, . 500 20, Wockhardt Ltd. 29
+---------------------------------------------------+------------+
, . 20, Actavis 31
+---------------------------------------------------+------------+
-, ( 18,8
-) 20% - 5 ,
-/
+---------------------------------------------------+------------+
, . 1 20, Novartis Consumer 68
+---------------------------------------------------+------------+
, 4% - 5 , 5,3
+---------------------------------------------------+------------+
, . / 20, Sopharma 30
+---------------------------------------------------+------------+
, 2% - 40 1, Actavis 45
+---------------------------------------------------+------------+
, . 250 10, 1,8
-
+---------------------------------------------------+------------+
C, . . 10, UPSA 39
+---------------------------------------------------+------------+
, 25 20, Berlin-Chemie/Menarini 62
group
+---------------------------------------------------+------------+
, . 10 20, Terapia SA 55
+---------------------------------------------------+------------+
, 2,5% 50 1, Berlin-Chemie/Menarini 145
group
+---------------------------------------------------+------------+
, 20, Aventis 30,5
+---------------------------------------------------+------------+
, . 500 10, 9
+---------------------------------------------------+------------+
, . 50 10, 1,6
+---------------------------------------------------+------------+
, 0,05% 100 , 9,49

+---------------------------------------------------+------------+
, . 25 50, Sopharma 10
+---------------------------------------------------+------------+
, . 6, 1,1
+---------------------------------------------------+------------+
, . 10 20, 15
+---------------------------------------------------+------------+
, . 10 20, KRKA 68
+---------------------------------------------------+------------+
, . 40 25, Berlin-Chemie/Menarini 94
group
+---------------------------------------------------+------------+
, . 300 30, Aventis 190
+---------------------------------------------------+------------+
, 0,1% - 10 1, 25
Warszaw pharmaceutical work Polfa
+---------------------------------------------------+------------+
, 2 , 1,8
+---------------------------------------------------+------------+
, . 20 10, 1,25
+---------------------------------------------------+------------+
, 0,1% - 10 1, Novartis 89
Consumer
L---------------------------------------------------+-------------


25%
   ----------------------------------------------------T------------

, . 250 24, 15,09

+---------------------------------------------------+------------+
, . 500 10, 1,64

+---------------------------------------------------+------------+
, . 480 20, Polfa Pabianickie 44,96
zaklady farmaceutyczne SA
+---------------------------------------------------+------------+
, 1% 20 1, Novartis Consumer 88,28
+---------------------------------------------------+------------+
, 1% 40 , Hemofarm D.D. 49,51
+---------------------------------------------------+------------+
, 5% - 2 1, GSK Consumer 144,91
Healthcare
+---------------------------------------------------+------------+
, . 10 10, Schering-Plough 164,45
+---------------------------------------------------+------------+
, 1 1, Aventis 83,33
+---------------------------------------------------+------------+
, 1% - 20 1, 42,50
GSK Pharmaceuticals
+---------------------------------------------------+------------+
, . / 500000 20, -/ 21,19

+---------------------------------------------------+------------+
, 0,5% - 5 10, 12,50

+---------------------------------------------------+------------+
, . 400 60, Pliva 146,99
+---------------------------------------------------+------------+
, 2% - 30 1, 13,13
+---------------------------------------------------+------------+
, . 12, GSK Consumer 75,14
Healthcare
+---------------------------------------------------+------------+
, . 25 20, Egis 75,49
+---------------------------------------------------+------------+
, . 250 20, Polpharma 51,70
+---------------------------------------------------+------------+
, . / 50 30, Lannacher 42,63
heimittel GmbH
+---------------------------------------------------+------------+
, . 150 1, 144,38
+---------------------------------------------------+------------+
, 16,50
1 1,
L---------------------------------------------------+-------------



   ------------------------------------------------------------------

--------------------

- , scomm@mail.ru